{"id":"NCT00409838","sponsor":"Bristol-Myers Squibb","briefTitle":"A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate","officialTitle":"A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Abatacept Administered Intravenously in Korean Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-04","primaryCompletion":"2008-07","completion":"2011-12","firstPosted":"2006-12-11","resultsPosted":"2010-01-26","lastUpdate":"2013-08-08"},"enrollment":113,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Abatacept","otherNames":["Orencia","BMS-188667"]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Abatacept","otherNames":["Orencia","BMS-188667"]},{"type":"DRUG","name":"Methotrexate","otherNames":[]}],"arms":[{"label":"Abatacept and Methotrexate","type":"EXPERIMENTAL"},{"label":"Placebo and Methotrexate","type":"PLACEBO_COMPARATOR"},{"label":"Abatacept - Open Label","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to demonstrate the clinical efficacy of abatacept (body-weight tiered dose approximating 10 mg/kg) compared with placebo on a background of methotrexate after 6 months (Day 169) of treatment in Korean patients with active rheumatoid arthritis and an inadequate clinical response to methotrexate","primaryOutcome":{"measure":"Percentage of Participants Meeting the Criteria of the American College of Rheumatology for 20% Improvement (ACR20)","timeFrame":"At Day 169","effectByArm":[{"arm":"Abatacept, 10 mg/kg","deltaMin":65.5,"sd":null},{"arm":"Placebo","deltaMin":42.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":7,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":["http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":55},"commonTop":["NASOPHARYNGITIS","UPPER RESPIRATORY TRACT INFECTION","COUGH","HEADACHE","DYSPEPSIA"]}}